BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1204279)

  • 1. Phenytoin and phenobarbital concentrations in saliva and plasma measured by radioimmunoassay.
    Cook CE; Amerson E; Poole WK; Lesser P; O'Tuama L
    Clin Pharmacol Ther; 1975 Dec; 18(6):742-7. PubMed ID: 1204279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Ames Seralyzer for the determination of carbamazepine, phenobarbital, and phenytoin concentrations in saliva.
    Miles MV; Tennison MB; Greenwood RS; Benoit SE; Thorn MD; Messenheimer JA; Ehle AL
    Ther Drug Monit; 1990 Sep; 12(5):501-10. PubMed ID: 2293415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A correlation between the levels of phenobarbital, phenytoin and valproic acid in the blood serum and in saliva from children treated due to epilepsy.
    Sobaniec W
    Mater Med Pol; 1989; 21(4):323-6. PubMed ID: 2489248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraindividual variability of carbamazepine, phenobarbital, and phenytoin concentrations in saliva.
    Miles MV; Tennison MB; Greenwood RS
    Ther Drug Monit; 1991 Mar; 13(2):166-71. PubMed ID: 2053125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of phenobarbitone and phenytoin therapy in small children by salivary samples.
    Mucklow JC; Bacon CJ; Hierons AM; Webb JK; Rawlins MD
    Ther Drug Monit; 1981; 3(3):275-7. PubMed ID: 7324092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary phenytoin radioimmunoassay. A simple method of the assessment of non-protein bound drug concentrations.
    Paxton JW; Rowell F; Ratcliffe JG; Lambie DG; Nanda R; Melville ID; Johnson RH
    Eur J Clin Pharmacol; 1977; 11(1):71-4. PubMed ID: 832662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenytoin-valproate interaction: importance of saliva monitoring in epilepsy.
    Knott C; Hamshaw-Thomas A; Reynolds F
    Br Med J (Clin Res Ed); 1982 Jan; 284(6308):13-6. PubMed ID: 6797618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monitoring therapy by analysis of the drug concentration of saliva].
    Bartels H; Günther E; Wallis S
    Monatsschr Kinderheilkd; 1983 Jan; 131(1):13-6. PubMed ID: 6835213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain concentrations of phenytoin, phenobarbitone and primidone in epileptic patients.
    Houghton GW; Richens A; Toseland PA; Davidson S; Falconer
    Eur J Clin Pharmacol; 1975 Oct; 9(1):73-8. PubMed ID: 1233256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Saliva phenobarbital concentration in epileptics].
    Shen D
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Dec; 22(6):369-70, 382. PubMed ID: 2638994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between the saliva and free serum concentration of phenobarbital in epileptic children.
    Tokugawa K; Ueda K; Fujito H; Kurokawa T
    Eur J Pediatr; 1986 Oct; 145(5):401-2. PubMed ID: 3792385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring phenytoin in salivary and plasma ultrafiltrates of pediatric patients.
    Bachmann K; Forney RB; Voeller K
    Ther Drug Monit; 1983; 5(3):325-9. PubMed ID: 6636260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free phenytoin monitoring in serum and saliva of epileptic patients in China.
    Cai WM; Zhu GZ; Chen G
    Ther Drug Monit; 1993 Feb; 15(1):31-4. PubMed ID: 8451777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study on cerebrospinal fluid and saliva to serum concentration ratios of anticonvulsants--Phenytoin, Phenobarbital, Valproic Acid and Primidone in epileptic patients].
    Kido H
    Seishin Shinkeigaku Zasshi; 1982; 84(9):661-79. PubMed ID: 6820506
    [No Abstract]   [Full Text] [Related]  

  • 15. Salivary phenytoin concentrations in epilepsy and in chronic renal failure.
    Reynolds F; Ziroyanis PN; Jones NF; Smith SE
    Lancet; 1976 Aug; 2(7982):384-6. PubMed ID: 73850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiepileptic drug distribution in cerebral cortex, ammon's horn, and amygdala in man.
    Sironi VA; Cabrini G; Porro MG; Ravagnati L; Marossero F
    J Neurosurg; 1980 May; 52(5):686-92. PubMed ID: 7373396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary levels of anticonvulsants: a practical approach to drug monitoring.
    McAuliffe JJ; Sherwin AL; Leppik IE; Fayle SA; Pippenger CE
    Neurology; 1977 May; 27(5):409-13. PubMed ID: 16232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma levels of diphenylhydantoin (DPH) and phenobarbitone (PB) in epileptic patients resistant to drug treatment (author's transl)].
    Zaccara G; Galli A; Rossi L; Zappoli R; Zatelli L; Amaducci L
    Riv Patol Nerv Ment; 1977; 98(6):363-75. PubMed ID: 754251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of plasma unbound phenobarbital concentration by using mixed saliva.
    Nishihara K; Uchino K; Saitoh Y; Honda Y; Nakagawa F; Tamura Z
    Epilepsia; 1979 Feb; 20(1):37-45. PubMed ID: 421675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenytoin and IgA concentrations in plasma and saliva in epileptic children.
    Modéer T; Tomson G; Falk O; Rane A
    Acta Paediatr Scand; 1981; 70(3):373-8. PubMed ID: 7246128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.